Zusammenfassung
Eine Alloantikörperentwicklung gegen den Faktor VIII bei hämophilen Patienten, wie auch eine Antikörperentwicklung bei nichthämophilen Patienten führt zumeist zur vollkommenen Unterbindung der Faktor-VIII-Aktivität.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Brackmann HH (1984) Induced immunotolerance in factor VIII inhibitor patients. Prog Clin Biol 150: 181–185
Brackmann HH, Formsen J (1977) Massive factor VIII infusion in hemophilic patients with factor VIII inhibitor. Lancet II; 933
Brackmann HH, Oldenburg J, Schwaab R (1996) Immune tolerance for the treatment of factor VIII inhibitors-Twenty years’ `Bonn Protocol’ Vox Sang 70: 30–35
Green D, Lechner K (1981) A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost 45: 200–203
Green D, Rademaker AW, Briet E (1993) A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies Thromb Haemost 70 (5): 753–757
Kessler, CM (1991) Aquired factor VIII inhibitors in the nonhemophiliac: Historical perspectives, current therapies, and future approaches. Am J Med 91 (5 A): 1–48
Knöbl P, Derfler K, Korninger L, Kapiotis S, Jager U, Maier-Dobersberger T, Horl W, Lechner K, Pabinger I (1995) Elimination of acquired factor VIII antibodies by extracorporal antibody-based immunadsorbtion (Ig-Therasorb). Thromb-Haemost. 74 (4): 1035–8
Lottenberg R, Kentro TB, Kitchins CS (1987) Acquired Haemophilia: A natural history study of 16 patients with factor VIII inhibitor receiving little or no therapy. Arch Intern Med 147: 1077–1081
Ludlam CA, Morrison AE, Kessler C (1994) Treatment of Acquired Hemophilia. Seminars in Hematology 31 2 (4): 16–19
Morrison AE (1995) Acquired haemophilia and its management. British Journal of Haematology 89: 231–236
Nilsson IM, Berntorp E, Zettervall O (1988) Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, Cyclophosphamide, and Factor VIII N Eng J Med 318: 947–50
Nilsson IM, Jonsson S, Sundquist SB, Ahlberg A, Bergentz SE (1981) A procedure for removing high titer antibodies by extracorporal protein A sepharose adsorption in hemophilia. Blood 58: 38–42
Nilsson IM, Freiburghaus C (1993) Treatment of patients with factor VII and IX inhibitors. Thromb Haemost 79: 56–9
Nilsson IM, Freiburghaus C (1995) Apheresis Inhibitors to Coagulation Factors Inhibitors to Coagulation Factors, Plenum Press, New York
Spero JA, Lewis JH & Hasaiba U (1981) Corticosteroid therapy for acquired FVIII-C inhibitors. British Journal of Haematology 48: 635–642
Zeitler H, Unkrig C, Brackmann H, Effenberger C, Hanfland D, Ko Y, Vetter H (1997) An immunmodulatory treatment of acquired hemophilia A with long-term-IgG-immunoadsorption, immunsupression, and antigensubstutiton-A modified Bonn-protocoll inducing immuntolerance ASH Meeting 39, (Abstract)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Hess, L. et al. (2000). Modifiziertes Bonn- und Malmö-Protokoll: Behandlung erworbener Hemmkörper bei Nichthämophilen . In: Scharrer, I., Schramm, W. (eds) 29. Hämophilie-Symposion. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59633-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-59633-9_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-65929-7
Online ISBN: 978-3-642-59633-9
eBook Packages: Springer Book Archive